Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - COST OF REVENUE
Cost of Revenue GERN - Geron Corporation
124 M
LAST VALUE
1157.11%
2 YEAR CAGR
57.61%
5 YEAR CAGR
29.77%
10 YEAR CAGR